RCM
MRNA icon

RA Capital Management’s Moderna MRNA Stock Holding History

RA Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,513,929
Closed -$30.8M – 30
2019
Q1 		$30.8M Sell
1,513,929
-397
-0% -$7.37K 1.33% 23
2018
Q4 		$23.1M Buy
+1,514,326
New +$24.9M 1.35% 22

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

RA Capital Management's MRNA Position: Q2 2019 in Review

RA Capital Management sold out of Moderna (MRNA) in Q2 2019, closing a stake of 1,513,929 shares — an estimated $30.8M sold.

RA Capital Management first reported a position in MRNA in Q4 2018 and held it in 2 quarters. The position peaked at $30.8M in Q1 2019. 138 funds tracked by Wall St. Rank hold MRNA as of Q2 2019.

  • RA Capital Management reported no remaining Moderna position as of Q2 2019 after selling out during the quarter.
  • RA Capital Management sold 1,513,929 Moderna shares in Q2 2019, an estimated $30.8M.
  • RA Capital Management first reported a position in Moderna in Q4 2018 and held it in 2 quarters.
  • RA Capital Management's Moderna position peaked at $30.8M in Q1 2019.
  • 138 funds tracked by Wall St. Rank held Moderna as of Q2 2019.

Based on RA Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.